Landos Biopharma, Inc. (LABP) 的整体财务健康评级为 B- 综合评分为 0 （满分5分）.
这表明公司面临一些值得关注的财务挑战. 评级截至 2024-05-23.
| 日期 | 评级 | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2024-05-23 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-22 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-21 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-20 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-17 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-16 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-15 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-14 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-13 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-10 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-09 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-08 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
